June 16, 2009 - In response to the molybdenum 99 (Mo-99) supply shortage, Covidien sent out a letter to its customers informing them of the anticipated Covidien generator and unit dose (UD) Tc 99m supply to the overall U.S., Canadian and Latin American markets through August 2009.

The update noted the National Research Universal (NRU) reactor in Chalk River, Canada, will be out of service for at least three months as reported by the Atomic Energy of Canada Ltd.; and the High Flux Reactor (HFR) in Petten, The Netherlands, has a planned shutdown in early July that is expected to last a few days.

Covidien has made arrangements through its diversified supply chain to the remaining online reactors in Belgium and South Africa, and have increased orders for Mo 99 from each reactor to partially offset the shortages caused by the HFR routine maintenance and ongoing NRU reactor shutdown.

Despite these efforts, the company expects there will still be a global shortage of Tc 99m generators during this period.

Covidien stated it should be able to supply its current customers, but not fully meet new demand coming from an influx of facilities seeking alternative suppliers of Mo-99. The company cautioned that at times it may not be able to fully meet even its current clients’ demand.

For more information: www.covidien.com


Related Content

News | Radiopharmaceuticals and Tracers

April 5, 2024 — RLS Radiopharmacies, America’s only Joint Commission-accredited radiopharmacy network, today announced ...

Time April 05, 2024
arrow
News | Quality Assurance (QA)

February 12, 2024 — IBA, a world leader in particle accelerator technology and a world-leading provider of dosimetry and ...

Time February 12, 2024
arrow
News | Interventional Radiology

February 6, 2024 — RenovoRx, Inc., a clinical-stage biopharmaceutical company developing novel precision oncology ...

Time February 06, 2024
arrow
News | Radiology Business

January 23, 2024 — Bayer announced Nelson Ambrogio as the new Head of the Radiology Business at its Pharmaceuticals ...

Time January 23, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

January 18, 2024 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved expanded MRI labeling ...

Time January 18, 2024
arrow
News | Radiology Business

December 14, 2023 — Nucleus RadioPharma, a fully integrated development, manufacturing, and supply chain organization ...

Time December 14, 2023
arrow
News | Radiation Oncology

October 17, 2023 — Radionetics Oncology, Inc., a clinical stage radiopharmaceutical company focused on the discovery and ...

Time October 17, 2023
arrow
News | Radiopharmaceuticals and Tracers

October 5, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time October 05, 2023
arrow
News | Radiation Therapy

September 20, 2023 — RefleXion Medical, Inc., a therapeutic oncology company and 3B Pharmaceuticals (3BP) GmbH, a ...

Time September 20, 2023
arrow
Feature | PET Imaging

According to a new report from Transparency Market Research (TMR), PET radiotracers are expected to rise at a CAGR of 8 ...

Time September 05, 2023
arrow
Subscribe Now